Korzeniewska-Koseła Maria
National Tuberculosis and Lung Diseases Research Institute, Department of Tuberculosis Epidemiology and Surveillance
Przegl Epidemiol. 2018;72(2):189-205.
To evaluate the main features of TB epidemiology in 2016 in Poland and to compare with the situation in the EU/EEA countries.
Analysis of case- based data on TB patients from National TB Register, data on anti-TB drug susceptibility testing results in cases notified in 2016, data from National Institute of Public Health- National Institute of Hygiene on cases of tuberculosis as AIDS-defining disease, data from Central Statistical Office on deaths from tuberculosis based on death certificates, data from ECDC report „ European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2018- 2016 data. Stockholm: European Centre for Disease Prevention and Control, 2018”.
In 2016, 6 444 TB cases were reported in Poland. The incidence rate was 16.8 cases per 100 000, with large variability between voivodships from 8.1 to 24.3 per 100 000. The average decline of TB incidence was 3.0% per year during 2012- 2016. 5 713 cases were new, never treated i.e. 14.9 per 100 000. 731 cases i.e. 1.9 per 100 000 – 11.3% of all registered subjects were previously treated. In 2016, 6 116 pulmonary tuberculosis cases occurred in Poland, equivalent to 15.9 per 100 000. Pulmonary cases represented 94.9% of all TB cases. The number of pulmonary TB cases with bacteriological confirmation was 4475 i.e. 12,0 per 100 000. In 2016, only 328 extrapulmonary TB cases were reported. Pediatric cases represented 1.6% of the total TB cases in Poland; 103 children with TB were notified. The incidence of tuberculosis has been growing along with the age group from 1.8 per 100 000 among children to 27.8 per 100 000 among patients aged 45 to 64 years. In the age group 65 years old and older the incidence was 26.0 per 100 000. The incidence among men i.e. 24.0 per 100 000 was >2 times higher than among women i.e. 10.0 per 100 000. The biggest difference in the TB incidence between the two sex groups occurred in persons aged 55 to 59 years – 51.9 vs. 11.5 and in subjects aged 60 to 64 years (45.9 vs. 11.7). The TB incidence in urban population was higher than in rural, respectively 17.3 per 100 000 and 15.9 per 100 000. In 2016, the number of all culture positive TB cases was 4619. Culture-confirmed cases represented 71.7% of all TB cases; culture-confirmed pulmonary TB – 73.2% of all pulmonary TB cases. In 2016, the number of smear-positive/culture positive pulmonary TB cases was 2612 (6.8 per 100 000) what represented 42.7% of all pulmonary TB cases. TB was initial AIDS indicative disease in 17 persons. In 2016, 46 cases with MDR-TB (among them 10 foreigners) and 101 patients with resistance solely to isoniazid were reported in Poland, representing respectively 1.1% and 2.4% of cases with known DST results (DSTs were done in 90.7% of all culture-confirmed TB cases). In 2016, there were 92 TB cases of foreign origin. In 2015, there were 537 deaths due to tuberculosis in Poland, which is equivalent to 1.4 deaths per 100 000 population; 520 people died from pulmonary and 17 from extrapulmonary tuberculosis. Mortality among males – 2.3 per 100 000 – was 3.8 x higher than among females – 0.6. The highest mortality rate was observed in subjects 65 years old and older – 3.3 per 100 000. There were no deaths from tuberculosis in children and adolescents. In 2015, TB mortality represented 0.14% of total mortality in Poland and 28.0% of mortality from infectious diseases.
In 2016, the incidence of tuberculosis in Poland was slightly higher than in 2015 and higher than the average in the EU/EEA countries. The highest incidence rates were observed in older age groups. The incidence in males was more than 2 times higher than in females. The impact of migration on the characteristics of tuberculosis in Poland is low. In Poland, tuberculosis in children, tuberculosis in persons infected with HIV and MDR-TB is less common than the average in the EU/EEA countries.
评估2016年波兰结核病流行病学的主要特征,并与欧盟/欧洲经济区国家的情况进行比较。
分析来自国家结核病登记处的结核病患者病例数据、2016年报告病例的抗结核药物敏感性检测结果数据、国家公共卫生研究所-国家卫生研究所关于作为艾滋病界定疾病的结核病病例数据、中央统计局基于死亡证明的结核病死亡数据、欧洲疾病预防控制中心报告“欧洲疾病预防控制中心/世界卫生组织欧洲区域办事处。2018 - 2016年欧洲结核病监测与监测数据。斯德哥尔摩:欧洲疾病预防控制中心,2018年”。
2016年,波兰报告了6444例结核病病例。发病率为每10万人16.8例,各省份之间差异很大,从每10万人8.1例到24.3例不等。2012 - 2016年期间,结核病发病率平均每年下降3.0%。5713例为新发病例,即从未接受过治疗,发病率为每10万人14.9例。731例,即每10万人1.9例,占所有登记病例的11.3%,为既往接受过治疗的病例。2016年,波兰发生了6116例肺结核病例,相当于每10万人15.9例。肺结核病例占所有结核病病例的94.9%。细菌学确诊的肺结核病例数为4475例,即每10万人12.0例。2016年,仅报告了328例肺外结核病病例。儿童病例占波兰结核病病例总数的1.6%;报告了103例儿童结核病病例。结核病发病率随年龄组增加而上升,从儿童中的每10万人1.8例增加到45至64岁患者中的每10万人27.8例。在65岁及以上年龄组中,发病率为每10万人26.0例。男性发病率为每10万人24.0例,是女性发病率每10万人10.0例的两倍多。两个性别组之间结核病发病率差异最大的是55至59岁人群,分别为51.9对11.5,以及60至64岁人群(45.9对11.7)。城市人口中的结核病发病率高于农村,分别为每10万人17.3例和每10万人15.9例。2016年,所有培养阳性结核病病例数为4619例。培养确诊病例占所有结核病病例的71.7%;培养确诊的肺结核病例占所有肺结核病例的73.2%。2016年,涂片阳性/培养阳性肺结核病例数为2612例(每10万人6.8例),占所有肺结核病例的42.7%。结核病是17人的初始艾滋病指示疾病。2016年,波兰报告了46例耐多药结核病病例(其中10例为外国人)和101例仅对异烟肼耐药的患者,分别占已知药敏试验结果病例的1.1%和2.4%(90.7%的所有培养确诊结核病病例进行了药敏试验)。2016年,有92例外国来源的结核病病例。2015年,波兰有537例结核病死亡病例,相当于每10万人口1.4例死亡;520人死于肺结核,17人死于肺外结核病。男性死亡率为每10万人2.3例,是女性死亡率每10万人0.6例的3.8倍。65岁及以上人群的死亡率最高,为每10万人3.3例。儿童和青少年中没有结核病死亡病例。2015年,结核病死亡率占波兰总死亡率的0.14%,占传染病死亡率的28.0%。
2016年,波兰的结核病发病率略高于2015年,且高于欧盟/欧洲经济区国家的平均水平。发病率最高的是老年人群体。男性发病率比女性高出两倍多。移民对波兰结核病特征的影响较小。在波兰,儿童结核病、艾滋病毒感染者结核病和耐多药结核病比欧盟/欧洲经济区国家的平均情况少见。